Delivery of affordable and equitable cancer care in India

Pramesh, C S; Badwe, Rajendra; Borthakur, Bibhuti Bhusan; Chandra, Madhu; Raj, Elluswami Hemanth; Kannan, T; Kalwar, Ashok; Kapoor, Sanjay; Malhotra, Hemant; Nayak, Smrutiranjan; Rath, Goura Kishor; Sagar, Tenali Gnana; Stolzmann, Paul; Sarin, Rajiv; Shanta, V.; Sharma, Suresh C.; Shukla, Shilin N.; Vijayakumar, M.; Vijaykumar, D K; Aggarwal, Ajay; Purushotham, Arnie; Sullivan, Richard

doi:10.1016/s1470-2045(14)70117-2

Cited by 189 publications

(178 citation statements)

References 45 publications

Supporting

Mentioning

177

Contrasting

Order By: Relevance

“…It is imperative to strengthen cancer control activities at the community with strong prevention messages, early screening and proper management as most of the common cancers are preventable [32].…”

Section: Discussionmentioning

confidence: 99%

Cost of hospitalisation for non‐communicable diseases in India: are we pro‐poor?

Tripathy¹,

Prasad²,

Shewade³

et al. 2016

Tropical Med Int Health

View full text Add to dashboard Cite

Abstractobjectives To estimate out-of-pocket (OOP) expenditure due to hospitalisation from NCDs and its impact on households in India.methods The study analysed nationwide representative data collected by the National Sample Survey Organisation in 2014 that reported health service utilisation and healthcare-related OOP expenditure by income quintiles and by type of health facility (public or private). The recall period for inpatient hospitalisation expenditure was 365 days. Consumption expenditure was collected for a recall period of 1 month. OOP expenditure amounting to >10% of annual consumption expenditure was termed as catastrophic. Weighted analysis was performed.results The median expenditure per episode of hospitalisation due to NCDs was USD 149 -this was~3 times higher among the richest quintile compared to poorest quintile. There was a significantly higher prevalence of catastrophic expenditure among the poorest quintile, more so for cancers (85%), psychiatric and neurological disorders (63%) and injuries (63%). Mean private-sector OOP hospitalisation expenditure was nearly five times higher than that in the public sector. Medicines accounted for 40% and 27% of public-and private-sector OOP hospitalisation expenditure, respectively.conclusion Strengthening of public health facilities is required at community level for the prevention, control and management of NCDs. Promotion of generic medicines, better availability of essential drugs and possible subsidisation for the poorest quintile will be measures to consider to reduce OOP expenditure in public-sector facilities.keywords non-communicable diseases, injury, cancer, out-of-pocket expenditure, catastrophic expenditure

show abstract

Section: Discussionmentioning

confidence: 99%

Cost of hospitalisation for non‐communicable diseases in India: are we pro‐poor?

Tripathy¹,

Prasad²,

Shewade³

et al. 2016

Tropical Med Int Health

View full text Add to dashboard Cite

show abstract

“…This results in loss of salary for the care givers and added financial burden to the already existing financial constraints towards cost of treatment. Major centers also face the burden of large number of patients thus creating a substantial waiting time for diagnosis, intervention and therapy (30). Our center is also a well-designed tertiary cancer care center and caters to a large patient population adding to the machine burden and prolonged waiting period for cancer directed therapy.…”

Section: Discussionmentioning

confidence: 99%

Treatment Compliance and Outcome in Geriatric Patients with Locally Advanced Non-Small Cell Lung Cancer: Experience from India

et al. 2016

View full text Add to dashboard Cite

Objectives: To evaluate treatment compliance, toxicity and survival in geriatric patients (≥65 years) with locally advanced nonsmall cell lung cancer (LA-NSCLC).Methods: Departmental archive was collected for the details of demographics, treatment and outcome in elderly patients with LA-NSCLC (2008 -2013) (n = 96). Both progression-free survival (PFS) and overall survival (OS) were evaluated using Kaplan-Meier method. Acute and late morbidity were scored using common terminology criteria for adverse events version 4, radiation therapy and oncology group late morbidity scoring system. Results:Overall treatment completion rate was 65%. The rates of acute grade ≥ 3 hematologic and non-hematologic toxicities were 20% and 17% respectively. Overall rate of late toxicity was 12.5%. The median PFS and OS values were 7.4 months and 10.54 months, respectively. Patients with multiple comorbidities, poor socio-economic background and serum albumin level (< 3.5g/dL) were observed to have poor survival. Survival was lower for non-compliant patients. Conclusions:Curative multi-modality therapy in elderly patients with LA-NSCLC is a challenging task. They are susceptible to poor compliance, treatment-associated toxicities and poor survival.

show abstract

“…Oral, cervical and breast cancers -cancers that are either preventable and/or amenable to early detection and treatment -are the leading causes of cancer-related morbidity and mortality in the country (Ferlay et al, 2014). Although India's National Cancer Control Programme was launched in 1976, large scale implementation of cancer prevention and control strategies has yet to take place, and public expenditures on cancer remain low (Pramesh et al, 2014). In this paper, we highlight implementation science research (IS) priorities that have the potential to catalyze cancer prevention in India.…”

Section: Introductionmentioning

confidence: 99%

Using Implementation Science to Advance Cancer Prevention in India

Krishnan

Sivaram

Anderson

et al. 2015

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Oral, cervical and breast cancers, which are either preventable and/or amenable to early detection and treatment, are the leading causes of cancer-related morbidity and mortality in India. In this paper, we describe implementation science research priorities to catalyze the prevention and control of these cancers in India. Research priorities were organized using a framework based on the implementation science literature and the World Health Organization's definition of health systems. They addressed both community-level as well as health systems-level issues. Community-level or "pull" priorities included the need to identify effective strategies to raise public awareness and understanding of cancer prevention, monitor knowledge levels, and address fear and stigma. Health systems-level or "push" and "infrastructure" priorities included dissemination of evidencebased practices, testing of point-of-care technologies for screening and diagnosis, identification of appropriate service delivery and financing models, and assessment of strategies to enhance the health workforce. Given the extent of available evidence, it is critical that cancer prevention and treatment efforts in India are accelerated. Implementation science research can generate critical insights and evidence to inform this acceleration.

show abstract

Delivery of affordable and equitable cancer care in India

Cited by 189 publications

References 45 publications

Cost of hospitalisation for non‐communicable diseases in India: are we pro‐poor?

Cost of hospitalisation for non‐communicable diseases in India: are we pro‐poor?

Treatment Compliance and Outcome in Geriatric Patients with Locally Advanced Non-Small Cell Lung Cancer: Experience from India

Using Implementation Science to Advance Cancer Prevention in India

Contact Info

Product

Resources

About